The Democratic Congressional Campaign Committee, citing the Center for Responsive Politics, said Katko has accepted more than $160,000 from individuals and PACs linked to pharmaceutical companies and manufacturers.
A conservative outside group, the American Action Network, has been airing ads supportive of Katko’s vote against the Democratic proposal and, most recently, included him in a $4 million digital, mail and TV ad campaign in support of the Republicans’ prescription drug price reform proposal.
The ads tout the legislation, which supporters say would lower drug costs while ensuring that innovation is preserved and new treatments are found for serious illnesses. That addresses one of the concerns raised by Katko and PhRMA, the trade group for pharmaceutical manufacturers, that it would “stifle” research and development.
The Congressional Budget Office offered preliminary projections about the effects of the Democrats’ bill on pharmaceutical research and development. The…